Use of lipid-lowering medications and the likelihood of achieving optimal LDL-cholesterol goals in coronary artery disease patients

Cholesterol

Volumn 2012, Issue , 2012, Pages

  Karalis, Dean G ^a,b   Victor, Brett ^b   Ahedor, Lilian ^b   Liu, Longjian ^c  

^a Cardiology Consultants of Philadelphia   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BILE ACID SEQUESTRANT; EZETIMIBE; FIBRIC ACID DERIVATIVE; FISH OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG POTENCY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 84864915536     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2012/861924     Document Type: Article

References (35)

1. Roger V. L., Go A. S., Lloyd-Jones D. M., Heart disease and stroke statistics2011 update: a report from the American Heart Association Circulation 2011 123 e18 e209
2. Smith S. C. Jr., Benjamin E. J., Bonow R. O., AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 2011 124 2458 2473
3. Heart Protection Study Collaborative Group, MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial The Lancet 2002 360 9326 7 22
4. Cannon C. P., Braunwald E., McCabe C. H., Rader D. J., Rouleau J. L., Belder R., Joyal S. V., Hill K. A., Pfeffer M. A., Skene A. M., Intensive versus moderate lipid lowering with statins after acute coronary syndromes The New England Journal of Medicine 2004 350 15 1495 1504 (Pubitemid 38477774)
5. LaRosa J. C., Grundy S. M., Waters D. D., Shear C., Barter P., Fruchart J. C., Gotto A. M., Greten H., Kastelein J. J. P., Shepherd J., Wenger N. K., Intensive lipid lowering with atorvastatin in patients with stable coronary disease The New England Journal of Medicine 2005 352 14 1425 1435 (Pubitemid 40471450)
6. Pedersen T. R., Faergeman O., Kastelein J. J. P., Olsson A. G., Tikkanen M. J., Holme I., Larsen M. L., Bendiksen F. S., Lindahl C., Szarek M., Tsai J., High-dose atorvastatin versus usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial Journal of the American Medical Association 2005 294 19 2437 2445 (Pubitemid 41627921)
7. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Intensive lowering of LDL cholesterol with 80mg versus 20mg simvastatin daily in 12, 064 survivors of myocardial infarction: a double-blind randomized trial The Lancet 2010 376 1658 1669
8. Cholesterol Treatment Trialists (CTT) Collaboration, Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials The Lancet 2010 376 1670 1681
9. Hsia J., MacFadyen J. G., Monyak J., Ridker P. M., Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol 50mg/dl with rosuvastatin: the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin) Journal of the American College of Cardiology 2011 57 16 1666 1675
10. Grundy S. M., Cleeman J. I., Merz N. B., Brewer H. B., Clark L. T., Hunninghake D. B., Pasternak R. C., Smith S. C., Stone N. J., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 2004 110 2 227 239 (Pubitemid 38924592)
11. Mosca L., Benjamin E. J., Berra K., Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American heart association Circulation 123 1243 1262
12. Brunzell J. D., Davidson M., Furberg C. D., Goldberg R. B., Howard B. V., Stein J. H., Witztum J. L., Kirkman M. S., Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation Diabetes Care 2008 31 4 811 822
13. Catapano A. L., Chapman J., Wiklund O., Taskinen M. R., The new joint EAS/ESC guidelines for the management of dyslipidaemias Atherosclerosis 2011 217 1 1
14. Karalis D. G., Subramanya R. D., Hessen S. E., Liu L., Victor M. F., Achieving optimal lipid goals in patients with coronary artery disease American Journal of Cardiology 2011 107 6 886 890
15. Ghandehari H., Kamal-Bahl S., Wong N. D., Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004 American Heart Journal 2008 156 1 112 119
16. Davidson M. H., Maki K. C., Pearson T. A., Pasternak R. C., Deedwania P. C., McKenney J. M., Fonarow G. C., Maron D. J., Ansell B. J., Clark L. T., Ballantyne C. M., Results of the National Cholesterol Education (NCEP) program evaluation project utilizing novel T-technology (NEPTUNE) II survey and implications for treatment under the recent NCEP writing group recommendations American Journal of Cardiology 2005 96 4 556 563 (Pubitemid 41132774)
17. Waters D. D., Brotons C., Chiang C. W., Ferrires J., Foody J., Jukema J. W., Santos R. D., Verdejo J., Messig M., McPherson R., Seung K. B., Tarasenko L., Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals Circulation 2009 120 1 28 34
18. Meade L. T., Barriers to achieving LDL cholesterol goals U.S. Pharmacist 2007 32 3 66 71 (Pubitemid 352024596)
19. Kauffman A. B., Olson K. L., Youngblood M. L., Zadvorny E. B., Delate T., Merenich J. A., Attainment of low-density lipoprotein cholesterol goals in coronary artery disease Journal of Clinical Lipidology 2010 4 3 173 180
20. Mosca L., Merz N. B., Blumenthal R. S., Cziraky M. J., Fabunmi R. P., Sarawate C., Watson K. E., Willey V. J., Stanek E. J., Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting Circulation 2005 111 4 488 493 (Pubitemid 40204434)
21. Kennedy A. G., MacLean C. D., Littenberg B., Ades P. A., Pinckney R. G., The challenge of achieving national cholesterol in patients with diabetes Diabetes Care 2005 28 5 1029 1034 (Pubitemid 40616608)
22. Stacy T. A., Egger A., Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs Journal of Managed Care Pharmacy 2006 12 9 745 751 (Pubitemid 47394435)
23. Yan A. T., Yan R. T., Tan M., Hackam D. G., Leblanc K. L., Kertland H., Tsang J. L., Jaffer S., Kates M. L., Leiter L. A., Fitchett D. H., Langer A., Goodman S. G., Contemporary management of dyslipidemia in high-risk patients: targets still not met American Journal of Medicine 2006 119 8 676 683 (Pubitemid 44128440)
24. Laforest L., Moulin P., Souchet T., Ritleng C., Desamericq G., Le Jeunne P., Schwalm M. S., Kieffer A., Van Ganse E., Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy Atherosclerosis 2008 199 2 368 377
25. Stein E., Stender S., Mata P., Sager P., Ponsonnet D., Melani L., Lipka L., Suresh R., MacCubbin D., Veltri E., Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin American Heart Journal 2004 148 3 447 455 (Pubitemid 39265117)
26. Davidson M. H., McGarry T., Bettis R., Melani L., Lipka L. J., LeBeaut A. P., Suresh R., Sun S., Veltri E. P., Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia Journal of the American College of Cardiology 2002 40 12 2125 2134 (Pubitemid 36005898)
27. Friedman H. S., Rajagopalan S., Barnes J. P., Roseman H., Combination therapy with Ezetimibe/Simvastatin versus Statin Monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical setting Clinical Therapeutics 2011 33 2 212 224
28. The SHARP Investigators, The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of Heart and Renal Protection): a randomized placebo-controlled trial The Lancet 2011 377 2181 2192
29. Taylor A. J., Villines T. C., Stanek E. J., Devine P. J., Griffen L., Miller M., Weissman N. J., Turco M., Extended-release niacin or ezetimibe and carotid intima-media thickness The New England Journal of Medicine 2009 361 22 2113 2122
30. Ballantyne C. M., Davidson M. H., McKenney J., Keller L. H., Bajorunas D. R., Karas R. H., Comparison of the safety and efficacy of a combination tablet of niacin extended release and Simvastatin versus Simvastatin monotherapy in patients with increased Non-HDL cholesterol (from the SEACOAST I study) American Journal of Cardiology 2008 101 10 1428 1436
31. The AIM-HIGH Investigators, Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy The New England Journal of Medicine 2011 365 2255 2267
32. Nichols G. A., Koro C. E., Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients Clinical Therapeutics 2007 29 8 1761 1770 (Pubitemid 47494553)
33. Foody J. M., Sajjan S. G., Hu X. H., Ramey D. R., Neff D. R., Tershakovec A. M., Tomassini J. E., Wentworth C., Tunceli K., Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients Journal of Clinical Lipidology 2010 4 2 126 132
34. The ACCORD Study Group, Effects of combination lipid therapy in type 2 diabetes mellitus The New England Journal of Medicine 2010 362 1563 1574
35. Howard B. V., Roman M. J., Devereux R. B., Fleg J. L., Galloway J. M., Henderson J. A., Howard W. J., Lee E. T., Mete M., Poolaw B., Ratner R. E., Russell M., Silverman A., Stylianou M., Umans J. G., Wang W., Weir M. R., Weissman N. J., Wilson C., Yeh F., Zhu J., Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial Journal of the American Medical Association 2008 299 14 1678 1689 (Pubitemid 351519865)